Lumexa Imaging — Third Quarter 2026 Earnings Summary

Lumexa Imaging reported third-quarter 2026 consolidated revenues of $272.0 million, representing a 5.0% increase from the prior year period, while net income turned positive at $7.2 million compared to a net loss of $3.5 million in the same quarter of 2025. The company achieved an Adjusted EBITDA of $62.6 million with a margin of 23.0%, driven by a 7.9% growth in advanced outpatient volumes and an improved procedure mix. Lumexa Imaging reiterated its full-year 2026 revenue guidance between $1.045 billion and $1.097 billion and narrowed its Adjusted EBITDA guidance range to $236 million–$240 million. Additionally, the company raised its full-year Adjusted EPS guidance to $0.86–$0.90 per share, reflecting a lower assumed effective tax rate and continued operational progress.